Boundless Bio, Inc.
BOLD
$1.44
-$0.06-4.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -16.45M | -16.51M | -16.98M | -15.43M | -12.14M |
| Total Depreciation and Amortization | 296.00K | 262.00K | 265.00K | 263.00K | 247.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.72M | 1.36M | 1.06M | 974.00K | 391.00K |
| Change in Net Operating Assets | -1.13M | 1.62M | -587.00K | -1.58M | -180.00K |
| Cash from Operations | -15.56M | -13.27M | -16.24M | -15.78M | -11.69M |
| Capital Expenditure | -466.00K | -483.00K | -1.50M | -83.00K | -268.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.29M | 22.61M | -66.69M | 18.22M | 16.08M |
| Cash from Investing | 1.82M | 22.13M | -68.19M | 18.14M | 15.81M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 113.00K | 0.00 | 93.00M | 59.00K | 39.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -329.00K |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -13.00K | -2.35M | -983.00K | -1.09M |
| Cash from Financing | 113.00K | -13.00K | 90.65M | -924.00K | -1.38M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.63M | 8.85M | 6.22M | 1.44M | 2.74M |